Home » Authors » Brady Huggett

Articles by Brady Huggett

Cell Therapeutics Starts NSCLC Phase III, Eyes One More In 2002

Oct. 8, 2002

By Brady Huggett

Cell Therapeutics Starts NSCLC Phase III, Eyes One More In 2002

Oct. 8, 2002

By Brady Huggett

Lilly Loans Isis $21M To Build Affinitac Manufacturing Space

Oct. 2, 2002

By Brady Huggett

Nastech Regains U.S. Rights For Nascobal From Schwarz

Oct. 2, 2002

By Brady Huggett

Lilly Loans Isis $21M To Build Affinitac Manufacturing Space

Oct. 2, 2002

By Brady Huggett

Nastech Regains U.S. Rights For Nascobal From Schwarz

Oct. 2, 2002

By Brady Huggett

IntraBiotics' Iseganan Fails To Reduce Mucositis In Phase III

Oct. 1, 2002

By Brady Huggett

IntraBiotics Pharmaceuticals Inc. stopped development of iseganan for mucositis following a Phase III failure. (BioWorld Today)

IntraBiotics' Iseganan Fails To Reduce Mucositis In Phase III

Oct. 1, 2002

By Brady Huggett

IntraBiotics Pharmaceuticals Inc. stopped development of iseganan for mucositis following a Phase III failure. (BioWorld Today)

Genome Therapeutics To Reduce Staff, Drop Early Research Efforts

Sep. 26, 2002

By Brady Huggett

Genome Therapeutics To Reduce Staff, Drop Early Research Efforts

Sep. 26, 2002

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...